Novel testosterone formulations are disclosed where testosterone is incorporated into a phospholipid/cholesterol system to produce a proliposomal powder dispersion. The proliposomal powder dispersions of the invention may be formulated with phamarceutically acceptable excipients to form pharmaceutical compositions. Enterically coated oral dosage forms are disclosed as are methods of treatment for testosterone replacement therapy.
申请公布号
SG11201407349U(A)
申请公布日期
2014.12.30
申请号
SG11201407349U
申请日期
2013.05.09
申请人
WESTERN UNIVERSITY OF HEALTH SCIENCES;TESORX PHARMA, LLC